PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 17 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A compound injection of Pyrola rotundifolia L and Astragalus membranaceus Bge protected the cochlea and kidney against gentamicin-induced injury in guinea pigs [PMID:7747908]
Pyrolaside B demonstrated significant antimicrobial activity against Gram-positive organisms Staphylococcus aureus and Micrococcus luteus in vitro [PMID:16079548]
Leaf extracts showed moderate radical scavenging and chelating activity and good inhibition of linoleic acid oxidation [PMID:32290223]
Evidence summary
PubMed sources
- 1.PMID: 18795339 (2008) — Fungal associates of Pyrola rotundifolia, a mixotrophic Ericaceae, from two Estonian boreal forests. · Mycorrhiza
- 2.PMID: 32290223 (2020) — Phenolic Composition of the Leaves of Pyrola rotundifolia L. and Their Antioxidant and Cytotoxic Activity. · Molecules (Basel, Switzerland)
- 3.PMID: 16079548 (2005) — Novel phenolic glycoside dimer and trimer from the whole herb of Pyrola rotundifolia. · Chemical & pharmaceutical bulletin
- 4.PMID: 3879592 (1985) — Studies on bioactive substances in crude drugs used for arthritic diseases in traditional Chinese medicine. III. Isolation and identification of anti-inflammatory and analgesic principles from the whole herb of Pyrola rotundifolia L. · Chemical & pharmaceutical bulletin
- 5.PMID: 26369596